Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Intensive "TOTAL THERAPY" for Untreated or Minimally Treated Patients With Multiple Myeloma

NCT00580372 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT00580372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00580372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Intensive "TOTAL THERAPY" for Untreated or Minimally Treated Patients With Multiple Myeloma
Lead sponsor
University of Arkansas
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2002
Completion date
October 31, 2015
Enrollment
231 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma